Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Wins $24M from US Government to Study Toxicogenomics

NEW YORK, Oct. 1 - Paradigm Genetics yesterday said it has been awarded $23.8 million from the National Institute of Environmental Health to perform gene-expression studies related to toxicology.


For the next five years, Paradigm researchers will use a gene-expression platform based on technology developed at Agilent Technologies to discern what happens to an organism when an undisclosed variety of toxicants, drugs, and pesticides have been introduced.


Paradigm added that this research will serve as a link between the company's ag-biotech and human-health research.


Click here for more information.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.